
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Bilberry leaf (Vaccinium myrtillus) is rich in chlorogenic acid, neochlorogenic acid, and triterpenes that neutralize reactive oxygen species, suppress NF-κB-mediated inflammation, and enhance endogenous antioxidant enzymes including superoxide dismutase and glutathione peroxidase. In preclinical models, bilberry leaf extracts significantly alleviated starch-induced hyperglycemia in both prediabetic and diabetic mice (PMID 32450572), while microencapsulated leaf phenolics demonstrated superior bioaccessibility and antioxidant capacity compared to unprocessed extracts (PMID 38068615).

Reported Benefits (Provisional)
Origin & History

Bilberry Leaf is derived from Vaccinium myrtillus, a shrub native to the boreal and temperate regions of Europe and parts of Asia. It thrives in forest understories and mountainous terrains, where it has been a staple in traditional medicine. The leaves are valued for their distinct phytochemical profile, offering unique benefits for metabolic and circulatory health.
Research Narrative (Provisional)
Takács et al. (2020) demonstrated that Vaccinium myrtillus leaf extracts significantly alleviated starch-induced hyperglycemia in prediabetic and diabetic mouse models, supporting its traditional use for blood sugar regulation (Planta Med, PMID 32450572). Kuzmanović Nedeljković et al. (2023) showed that microencapsulated bilberry leaf extracts preserved high phenolic content and exhibited potent antioxidant activity, confirming their potential for functional health applications (Plants, PMID 38068615). Ginovyan et al. (2023) identified anti-cancer and antibiotic-modulation mechanisms in V. myrtillus extracts, linking polyphenolic fractions to inhibition of bacterial efflux pumps and cytotoxic activity against tumor cell lines (Discov Med, PMID 37553312). Ferlemi and Lamari (2016) provided a comprehensive review confirming that berry leaves, including bilberry, contain higher concentrations of certain bioactive phenolics than the fruit itself, with demonstrated antioxidant, hypoglycemic, and anti-inflammatory properties in multiple experimental models (Antioxidants, PMID 27258314).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Vitamin K: Supports vascular health and bone metabolism. - Manganese: Essential for enzymatic function and antioxidant defense. - Copper: Facilitates energy production and immune resilience. - Polyphenols (Flavonoids, Phenolic Acids): Deliver antioxidant, anti-inflammatory, and metabolic-regulating effects. - Tannins: Contribute to astringent and antimicrobial properties, supporting digestive health.
Reported Mechanism (Provisional)
Bilberry leaf's primary phenolic acids—chlorogenic acid, neochlorogenic acid, and caffeic acid—scavenge superoxide anion, hydroxyl, and peroxyl radicals while upregulating endogenous antioxidant enzymes including superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) via Nrf2/ARE pathway activation. Triterpenes such as oleanolic acid and ursolic acid suppress pro-inflammatory cascades by inhibiting IκB kinase phosphorylation, thereby preventing NF-κB nuclear translocation and downstream production of TNF-α, IL-6, and COX-2. The leaf's flavonoid glycosides, including quercetin and kaempferol derivatives, inhibit α-glucosidase and α-amylase activity, slowing carbohydrate digestion and attenuating postprandial blood glucose spikes—a mechanism confirmed in diabetic mouse models (PMID 32450572). Additionally, proanthocyanidins in bilberry leaf modulate gut microbiota composition and strengthen intestinal barrier integrity by promoting short-chain fatty acid production.
Clinical Narrative (Provisional)
Human clinical data for bilberry leaf remains limited, with only one 24-hour safety study in human volunteers demonstrating good tolerability. Most evidence comes from in vitro and preclinical studies showing significant bioactivity, including 27.6% reduction in NF-κB activation in LPS-stimulated human monocytes, though this data primarily reflects fruit extracts. Animal models confirm antioxidant, anti-inflammatory, and hypoglycemic properties, but controlled human trials are needed to establish therapeutic dosages and clinical efficacy. The evidence base is promising but requires substantial clinical validation.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







